Ignite Creation Date:
2025-12-25 @ 5:07 AM
Ignite Modification Date:
2026-03-14 @ 6:55 AM
Study NCT ID:
NCT00855127
Status:
WITHDRAWN
Last Update Posted:
2015-06-01
First Post:
2009-03-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
New Urine and Blood Markers for Acute Kidney Injury in Liver Transplant Patients
Sponsor:
University of Colorado, Denver
Organization:
Study Overview
Official Title:
Early Biomarkers of Acute Kidney Injury in Liver Transplant Patients
Status:
WITHDRAWN
Status Verified Date:
2015-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
no enrollment
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to find new blood and urine tests that detect acute kidney injury earlier than our current blood tests in patients receiving a liver transplant.
Detailed Description:
Patients with end stage liver disease that receive a liver transplant will be studied to determine if novel serum and urine biomarkers (serum cystatin C, urine interleukin-18 \[IL-18\] and urine neutrophil gelatinase associated lipocalin \[NGAL\]) can predict the outcome measures listed above.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: